75
Chapter 9: DNA-Based Information Technologies DNA cloning: the basics Genes to genomes Genomes to proteomes Genome alterations/new biotechnology products

Chapter 9-V2

  • Upload
    billy82

  • View
    551

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Chapter 9-V2

Chapter 9:DNA-Based Information Technologies

DNA cloning: the basics

Genes to genomes

Genomes to proteomes

Genome alterations/new biotechnology products

Page 2: Chapter 9-V2

Tuesday, Apr 24ESB 1001

3:30 PM (W.E. Palke Memorial Lecture)Bruce Berne-  Columbia University

Hydrophobibity and Drying in Physical and Biological Systems

BMSE SeminarFriday April 27, 2007

3:00pmWebb 1100

SILVIA CAVAGNEROUniversity of Wisconsin-Madison

Department of ChemistryProtein folding at birth: experimental and computational

studies on and off the ribosome

Page 3: Chapter 9-V2

Biochemistry: isolation and study of individual cellular components and their reassembly

Much of this is defined by the genome

Ability to manipulate genes/genomes (1974): Berg/Boyer/Cohen

DNA cloning (recombinant DNA technology/genetic eng.)

endonucleases, vectors, ligation, propagation, selection

Type II restriction endos (Arber/phage/restriction/modification)

Page 4: Chapter 9-V2
Page 5: Chapter 9-V2

Overview of DNA cloningEpisomal DNA (plasmid)

Page 6: Chapter 9-V2
Page 7: Chapter 9-V2
Page 8: Chapter 9-V2
Page 9: Chapter 9-V2
Page 10: Chapter 9-V2
Page 11: Chapter 9-V2

EcoRV endonuclease: Mg++ dependent, blunt cutter, phosphodiesterase

Page 12: Chapter 9-V2
Page 13: Chapter 9-V2
Page 14: Chapter 9-V2

Prediction of site numberOrigin (200 bp, timing, plasmid specific)

Page 15: Chapter 9-V2

Plasmid cloning (libraries)

Page 16: Chapter 9-V2
Page 17: Chapter 9-V2
Page 18: Chapter 9-V2

Form of replica plating

Page 19: Chapter 9-V2

Replica plating

Page 20: Chapter 9-V2

Bacteriophage λ cloning vectors

48 Kb, ds DNA, linear

Remove genes not needed for phage replication

“Filler” genes

Capsids

Page 21: Chapter 9-V2
Page 22: Chapter 9-V2
Page 23: Chapter 9-V2

Bacterial artificial chromosomes (BACS) (John Carbon, UCSB, and others)

Cloning of 100-300Kb segments

Page 24: Chapter 9-V2

Yeast (eukaryotic) artificial chromosomes (YACS)

Yeast genome only 4X E.coli (14 x 106 bp)

Origin, CEN, telomeres, selectable markers

Page 25: Chapter 9-V2
Page 26: Chapter 9-V2
Page 27: Chapter 9-V2

Hybridization to identify clone/DNA segment

Selection vs screen

Page 28: Chapter 9-V2
Page 29: Chapter 9-V2
Page 30: Chapter 9-V2

Redundant probes (23 = 8)

Hybridization probe design

Page 31: Chapter 9-V2

Typical E.coli expression vector

Q: name two-three expression vectors sold by New England Biolabs, Invitrogen, Promega, Stratagene and their unique features

Page 32: Chapter 9-V2

Site directed mutagenesis (protein engineering, genetic engineering)…two approaches

Current method (Stratagene, Quickchange)

Page 33: Chapter 9-V2

9.2 From genes to genomes

•DNA libraries

•Contigs

•Sequence-tagged sites (STS)

•cDNAs/cDNA libraries

•Expression sequence tag (EST)

Page 34: Chapter 9-V2

Ordering of clones in DNA library

Markers

Contig: long contiguous segmentSTS: sequence-tagged site (markers)

Page 35: Chapter 9-V2

cDNA library from mRNAPoly T cellulose

Page 36: Chapter 9-V2
Page 37: Chapter 9-V2
Page 38: Chapter 9-V2

Reporter constructs, GFP, gene fusions, epitope tagsCellular, tissue, subcellular expression/localization

C.elegans, fusion protein expressed in specific neurons

Page 39: Chapter 9-V2
Page 40: Chapter 9-V2

PCR, Mullis, Nobel prize, CEN article

Page 41: Chapter 9-V2
Page 42: Chapter 9-V2
Page 43: Chapter 9-V2
Page 44: Chapter 9-V2

Cloning of amplified DNA

Page 45: Chapter 9-V2
Page 46: Chapter 9-V2
Page 47: Chapter 9-V2

RFLPs, SNPS

Page 48: Chapter 9-V2

The $1000 genomeGenomics, pharmacogenomics, toxicogenomicsPersonalized medicine, molecular diagnostics

Page 49: Chapter 9-V2

Viral DNASilenced by DNA methylation

Page 50: Chapter 9-V2

9.3 Genomes to proteomes

ProteomicsPhenotypicCellularMolecular

Comparative genomicsSynteny (conserved gene order)

Page 51: Chapter 9-V2

Cellular gene expressionGenetic networks 35,000 human genes1013 cellsHow controlled/regulated?

2D PAGE/MSGene chipsAffymetrixChip on Chip

Page 52: Chapter 9-V2
Page 53: Chapter 9-V2
Page 54: Chapter 9-V2
Page 55: Chapter 9-V2
Page 56: Chapter 9-V2
Page 57: Chapter 9-V2
Page 58: Chapter 9-V2

Genetic regulatory networks

Page 59: Chapter 9-V2

Recent method…Chip on Chip

Common strategies to “read the genome/proteome”

mRNA analysis

2D-PAGE and MS/MS

How to identify active regulatory parts of the genome which control transcription?

Page 60: Chapter 9-V2

Yeast two hybrid: identification of interacting proteins

Page 61: Chapter 9-V2
Page 62: Chapter 9-V2

9.4 Genome alterations and biotech productsPlant bacterial parasite used for cloning (no plasmids)Agrobacterium (crown gall formation)

Page 63: Chapter 9-V2
Page 64: Chapter 9-V2

Two plasmid approach to make recombinant plants

Page 65: Chapter 9-V2
Page 66: Chapter 9-V2
Page 67: Chapter 9-V2

Tobacco plant expressing firefly luciferase

Page 68: Chapter 9-V2
Page 69: Chapter 9-V2

RoundupEngineered plants

Page 70: Chapter 9-V2

Retroviral vectors for mammalian cell cloning (gene therapy)Cell/tissue specificityEmasculated virusSilencing

Page 71: Chapter 9-V2
Page 72: Chapter 9-V2
Page 73: Chapter 9-V2

Spatial/temporal control over gene regulation: basic research/therapeutics of the future

Page 74: Chapter 9-V2
Page 75: Chapter 9-V2